Methyltestosterone

甲睾酮

Report date: 2023/03/21 20:00:39
NME

Base Information

Drug NameMethyltestosterone
Drug Alias Name甲基睾丸素17-Methyltestosterone甲基睾酮甲基睾丸酮甲基睾固酮 +[8] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionAndrogen Receptor agonists
TargetsAndrogen Receptor
Therapy Area/IndicationsMenopausal symptomsHot FlashesHypogonadism +[6] 
Global Approved IndicationsHypogonadismBreast Neoplasms
Approved Indications in ChinaHypogonadismBreast Neoplasms
Original Approved Country/TerritoryMainland China
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesRussian Federation +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesTianjin Lisheng Pharmaceutical Co Ltd
Inactive CompaniesNovartis Pharmaceuticals Canada IncYale UniversitySolvay Pharmaceuticals
Active IndicationsHypogonadismBreast Neoplasms
Inactive IndicationsMenopausal symptomsHot FlashesHypertension +[4] 

Other Information

ATC CodeG03BA02G03EK01
Related LinksWikipediaDrugBankKEGG